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INTRODUCTION
Radiotherapy (RT) for head and neck tumors is a commonly used 
therapeutic modality due to its effectiveness and minimal aes-
thetic impact. However, given the close proximity of vital struc-
tures in the head and neck, such an intervention is not without 
side effects. These are not limited to the ear structures but may 
extend to the surrounding central nervous system, vessels, joints, 
and bones as well as the overlying skin. There exist numerous 
reports of side effects such as osteoradionecrosis, cranial nerve 
palsies, and, in the context of this paper, hearing loss.
  Sensorineural hearing loss is a well-known side effect of con-
ventional radiotherapy due to damage to the cochlear and audi-
tory pathways, as they are often included in the radiation fields 
(1). Prospective studies showed that this could result in sensori-
neural hearing losses that were severe to profound (2). Studies 
using animal models have demonstrated that high doses of radi-
Objectives. Radiotherapy for head and neck tumors is known to potentially induce sensorineural hearing loss, which is pos-
sibly due to damage to the cochlear and/or auditory pathways. Since the success of cochlear implantation depends on 
a functional auditory nerve, this paper aims to study the hearing outcomes of cochlear implantation in irradiated ears. 
Methods. A retrospective study of cochlear implant recipients from our institution who had previously received radiothera-
py for head and neck cancers was performed. A control group with cochlear implants who did not receive radiothera-
py was recruited. A review of case records, speech discrimination scores (SDS), and a validated subjective question-
naire in the form of the Abbreviated Profile of Hearing Aid Benefit (APHAB) was administered to the study group 
who fulfilled the inclusion criteria. Global and category scores in both groups were averaged and statistically com-
pared via non-inferiority (NI) testing.
Results. With the control group (n=8) as the reference, the -ΔNI was defined, and a one-tailed lower 95% confidence inter-
val was used for the irradiated group (n=8). The APHAB degree of improvement (%) results were as follows: global, 
28.9% (19.32%, -ΔNI=16.3%); ease of communication, 67.0% (58.36%, -ΔNI=37.5%); background noise, 53.2% 
(44.14%, -ΔNI=26.8%); reverberation, 41.7% (28.85%, -ΔNI=32.7%); and aversiveness, -46.2% (-67.80%, -ΔNI=
-56.9%). The SDS was 66.9% (56.02%, -ΔNI=51.0%). From the results, lower 95% confidence interval limits of 
global APHAB, SDS, ease of communication, and background noise scores of the irradiated group were within the 
defined -ΔNI boundary and hence are not inferior to the control. The categories of reverberation and aversiveness 
could not be proven, however. 
Conclusion. This study demonstrated marked improvements in hearing measured both objectively and subjectively. The 
overall hearing outcomes after cochlear implantation for post-irradiated patients were not worse than patients who 
have had no prior irradiation to ear structures.
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ation led to destruction of auditory nervous pathways (3). Amidst 
such well-established evidence, Low et al. (1) showed the ab-
sence of retro-cochlear ill effects following therapeutic irradia-
tion for patients with nasopharyngeal carcinoma (NPC) using 
auditory brainstem response audiometry. This study demonstrat-
ed no statistical difference between inter-wave latencies record-
ed during and after RT as compared to those recorded before RT.
  Although it is well known that cochlear implants (CI) have 
utility in restoring hearing loss from etiologies such as trauma 
and presbycusis, the effectiveness of cochlear implantation radi-
ation-induced deafness remains unclear. In the current literature, 
there are only a handful of case reports and case series that sug-
gest cochlear implantation as an effective rehabilitative tool in 
mitigating hearing loss in patients who received RT to the head 
and neck (4-7). These observations were consistent with the find-
ing that the retro-cochlear pathways were functionally spared in 
modern day radiotherapy of head and neck cancers (1). In view 
of the scarcity of evidence in this aspect, more clinical studies 
on the feasibility of CI in irradiated ears are warranted. 
  This non-inferiority study aims to further enhance the belief 
that CI can serve as a viable option in restoring hearing in deaf-
ened patients who had previously received radiotherapy for head 
and neck cancers. We studied post-implanted patients, compar-
ing a group of patients with previously irradiated ears with a 
group of controls who have not received radiotherapy before. 
MATERIALS AND METHODS
A retrospective review of all patients who had received CI at our 
institution was conducted. All CI recipients who had a history of 
having received conventional RT for NPC were identified. For 
this subset of patients, besides a review of case records, all were 
assessed by the validated questionnaire of Abbreviated Profile 
of Hearing Aid Benefit (APHAB) as well as a speech discrimina-
tion test. A control group of equivalent patients who had received 
CI for reasons other than post-irradiation were also recruited to 
serve as the reference. 
  Speech discrimination testing was administered aided by a cer-
tified team of audiologists and performed in a quiet listening situ-
ation in an audiometric booth using a 50 item Arthur Boothroyd 
(AB) words listing in the appropriate language medium. This was 
presented using a live voice with the subject seated at a distance 
of one meter from the tester. The presentation level was at a 
normal conversational level, and scores were calculated based 
on the number of correctly repeated phonemes. The validated 
APHAB questionnaire was explained and administered by the 
same investigator for all patients in the appropriate language 
medium. 
APHAB
The APHAB is comprised of an inventory of 24 items scored in 
four six-item subscales. Three of the subscales address speech 
understanding in various everyday environments: ease of com-
munication (EC, under relatively favorable conditions), listening 
under reverberant conditions (RV, communication in reverber-
ant rooms such as halls or churches), and listening in background 
noise (BN, in settings with high background noise levels). The 
fourth subscale measures the negative reactions to environmen-
tal sounds: aversiveness of sounds (AV). Each question was scored 
accordingly to a seven point Likert scale (for the purposes of 
this study numbered 0-6), whereby a higher score signifies more 
problems the subject faces in their daily lives. Of note was that 
several of the individual APHAB questions have “reversed” an-
swers; these were transposed during analysis so that all larger 
numeric responses indicated worse performance or more prob-
lems. To facilitate ease of calculation, each category was scored 
upon a subtotal of 36 points; the final global score of all four 
categories was scored upon a total of 144 points. Their percent-
ages were computed, and a degree of hearing benefit (%) was 
derived (non aided scores-aided scores). The speech discrimina-
tion test uses a validated AB words list whereby the higher the 
percentage score indicates the better the performance of the pa-
tient; in this domain, the aided scores were subtracted from the 
non-aided scores.
Radiotherapy technique
All patients were treated with six megavolt (6 MV) X-rays from 
linear accelerators. Chemotherapy was not part of the protocol 
for any patient. The primary volume covered the nasopharynx, 
including the Eustachian tube, adjacent parapharynx to the level 
of the inferior border of C2, and posterior third to half of the 
nasal cavity and maxillary antra. The brainstem was shielded 
throughout on the lateral fields, and the inner ear would be at 
the edge of this shield. A total dose of 66-70 Gy in 2 Gy daily 
increments was prescribed. The neck received 60 Gy electively, 
with palpable nodes boosted to 70 Gy.
Statistical method
The mean values and standard deviations for both irradiated 
and control groups were compared using an independent group 
T-test to ascertain if there was a significant difference in their 
degree of hearing benefit. The APHAB and speech discrimina-
tion scores (SDS) prior and after CI were also tabulated to fur-
ther compare the similarity of both groups as well as allow the 
authors to make a descriptive comparison.
  The control group results were used as the reference to ensure 
uniformity in the geographical context in which the study was 
conducted. This was also due to the fact that the APHAB was 
originally developed for hearing aids, and its use in the assess-
ment of CI has largely been confined to small samples in the 
context of CI fitting strategies (8-10). There are currently no 
substantial large-scale studies using this clinical utility to ascer-
tain the norm values in current CI users that we can use as a ref-Soh JM et al.: Cochlear Implant in Irradiated Ears    S95
erence. 
  A non-inferiority (-ΔNI) margin was arbitrarily decided upon 
and is defined as a degree of hearing benefit (%) change of 16.3 
(smallest observable change on the Likert scale) for the APHAB 
categories and 20% for the SDS based on clinical experience 
for an observable objective difference. As long as the lower con-
fidence interval of the irradiated group does not exceed the -ΔNI 
margin, the subcategory is considered to have performed as well 
as the controls. If the lower confidence interval exceeds this 
margin, then we cannot conclusively prove the result.
RESULTS
A total of 8 patients (3 females and 5 males) aged 57 to 72 years 
fulfilled the above criteria and consented to participate in the 
study. All were diagnosed with NPC, treated with RT from the 
period of 1979 to 2002, and received CI between the years 2000 
and 2010. All patients had a minimum of three years of profound 
sensorineural hearing loss prior to CI. All patients identified were 
evaluated at a minimum of one year post-implantation.
  With the control group (n=8) as the reference, the -ΔNI was 
defined, and a one-tailed lower 95% confidence interval was 
used for the irradiated group (n=8). 
Comparison of APHAB and SDS results
Fig. 1 depicts the mean responses for APHAB and SDS for both 
the irradiated and control groups in the unaided listening condi-
tion prior to their cochlear implantation. The average frequency 
of problems (represented as percentages) without the use of am-
plification was similar in both groups, and no significant differ-
ences (P>0.05) were observed between the means of the sub-
categories of BN, RV, AV, global scores and SDS when subjected 
to an independent samples T-test. There was statistical signifi-
cance found in the EC scores with T-testing, indicating that there 
were more problems in the EC domain reported in the irradiated 
group (X
_
, 97.9%; standard deviation [SD], 5.89) as compared to 
the control (X
_
, 83.0%; SD, 16.4; t=2.428; P=0.029) with 95% 
confidence intervals 1.74 and 28.12, respectively. Given the 
small sample of patients, it would be reasonable to conclude 
that patients in the irradiated group were largely similar to the 
control group in most domains except for EC. For the purposes 
of this study, more emphasis would be placed on the degree of 
hearing benefit and whether this benefit is similar in both groups.
  Fig. 2 depicts the mean responses for APHAB and SDS for 
both the irradiated and control groups in the aided listening 
condition status post CI with a minimum of 1 year of usage of 
the CI prior to being inducted into the study. The average fre-
quencies of problems (represented as percentages) between the 
groups were similar with T-testing that revealed non-significant 
differences in all sub categories (P>0.05). This suggests that the 
subjective and objective results were comparable in both groups 
and that the patients in the irradiated group were able to per-
form to a level similar to that of the controls.
  Fig. 3 and Table 1 present the comparison of the average ben-
efit for the irradiated and control groups. The average benefit 
score is given for both groups for each subcategory. As suggested 
by the aided scores, the data revealed similar mean responses 
between the two groups in terms of the degree of hearing benefit 
improvement in all subcategories. T-testing supported this find-
ing, and the comparison of mean hearing benefit scores showed 
non-significant differences between the two groups (P>0.05).
  A further test of NI was undertaken to further prove that 
those who suffer from hearing loss due to previously received 
irradiation have been able to attain a mean degree of hearing 
benefit that is not worse when compared to the controls. A one-
Fig. 1. Mean responses for Abbreviated Profile of Hearing Aid Bene-
fit (APHAB) & speech discrimination scores (SDS) for both the irradi-
ated and control groups in the unaided listening condition prior to 
their cochlear implantation. EC, ease of communication; BN, back-
ground noise; RV, reverberation; AV, aversiveness. Error bars, +/- 1 
SD.
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Fig. 2. Mean responses for Abbreviated Profile of Hearing Aid Bene-
fit (APHAB) & speech discrimination scores (SDS) for both the irradi-
ated and control groups in the aided listening condition status post 
cochlear implants (CI) with a minimum of 1 year of usage of the CI 
prior to being inducted into the study. EC, ease of communication; 
BN, background noise; RV, reverberation; AV, aversiveness. Error 
bars, +/- 1 SD.
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tailed 95% confidence interval was established for all subcate-
gories and compared in Figs. 4 and 5. The subcategories of EC, 
BN, global, and SDS scores have a mean difference and a lower 
confidence interval that was within the -ΔNI boundary of -16.6% 
(-20.0% for SDS). Whereas for the subcategories of RV and AV, 
despite having a mean difference as compared to controls of 
-7.29% and -5.55%, respectively, which was well within the 
-ΔNI boundary, the lower 95% confidence limits of -23.0% (RV) 
and -31.9% (AV) exceeded the lower limit of -ΔNI. This indicates 
that for the subcategories of EC, BN, global, and SDS, the irradi-
ated group under study was not worse off compared to controls, 
but that is not the case for the subcategories of RV and AV. In 
addition, the T-testing done on the mean differences for all sub-
categories revealed a P>0.05, indicating no significant differenc-
es between the groups.
DISCUSSION
Sensorineural hearing loss as a result of RT treatments to the 
head and neck region can result with doses as low as 30 Gy (7). 
In Asians, patients suffering from NPC receiving RT treatments 
are the largest group at risk for radiation induced hearing loss. 
Fig. 3. Comparison of the mean degree of hearing benefit for the ir-
radiated and control groups. EC, ease of communication; BN, back-
ground noise; RV, reverberation; AV, aversiveness; SDS, speech dis-
crimination scores. Error bars, +/- 1 SD.
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Fig. 4. Non-inferiority diagram depicting the mean differences for each 
subcategory of Abbreviated Profile of Hearing Aid Benefit between 
the irradiated and control groups.
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Fig. 5. Non-inferiority diagram depicting the mean differences for 
speech discrimination score (SDS) subcategory between the irradi-
ated and control groups.
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Table 1. T-test values from comparison of means from irradiated and control groups 
Subcategory
Levene’s test for  
equality of variances
T-test for equality of means
-ΔNI 
boundary/%
F Sig t df
Sig. 
(2-tailed)
Mean  
difference
SE  
difference
Lower 95% CI of 
the difference
Ease of communication 0.361 0.557 1.758 14 0.101 0.132 0.075 0.000 -16.6
Background noise 0.017 0.899 1.352 14 0.198 0.102 0.075 -0.031
Reverbertion 1.922 0.187 -0.820 14 0.426 -0.073 0.089 -0.230
Aversiveness 0.540 0.475 -0.371 14 0.716 -0.056 0.150 -0.319
Global 0.020 0.890 0.351 14 0.731 0.026 0.075 -0.106
Speech discrimination score 0.194 0.666 -0.460 14 0.653 -0.041 0.090 -0.199 -20.0
SE, standard error; CI, confidence interval; NI, non-inferiority. 
Such a phenomenon is common but often ignored, with report-
ed incidences varying up to 54% after RT (11, 12). This is more 
common in older patients, with a 37% incidence in those over 
50 years old (13). Post-irradiation sensorineural hearing loss can 
occur as early as 3 months to 1 year after treatment, and, as evi-
dent from clinical experience, it tends to be progressive, eventu-
ally leading to complete hearing loss (2).
  Low et al. (1) suggested that there was sparing of the retro-
cochlear auditory pathways in a study of 27 patients by demon-
strating no statistical difference between inter-wave latencies re-Soh JM et al.: Cochlear Implant in Irradiated Ears    S97
corded during and after RT as compared to those recorded be-
fore RT. As such, the preservation of retro-cochlear pathways 
meant that CI could be a viable solution to aid such patients in 
restoring hearing loss to a reasonable level to that prior to RT. 
  From our center’s experience and through the results of this 
study, the use of CI in such a group of patients has yielded good 
responses. However, there are currently no large-scale studies 
available that could have established the norm values of APHAB 
scores in non-irradiated CI patients. The closest obtainable re-
sults come from a study of 10 patients by Skarzynski et al. (14), 
in which the APHAB scoring done for this group of partial deaf-
ness CI patients reflects a similar degree of hearing benefit, with 
an average change hovering between 30-40% for all APHAB 
subcategories except for AV (measures unpleasantness of envi-
ronmental sounds), which had a cumulative negative change of 
about 30% over a 12-month period. These results mirror that 
seen in the controls of this study, which serve to further strength-
en the reliability of this reference group. A possible explanation 
for the negative change in the AV subcategory for both studies 
could be due to the fact that the patients under study suffer pro-
found hearing loss and would naturally report near zero distur-
bances in environmental sounds; upon receiving the implant, 
time is required to get accustomed to the sounds. Another study 
investigating the use of bilateral versus unilateral CI also utilized 
the APHAB; however, no raw values were provided, and the 
scoring method was modified (9). There are larger studies to 
measure outcomes involving CI in elderly patients for various 
etiologies not otherwise specified (15, 16). Unfortunately, the 
APHAB was not employed, and the standard results were only 
established for the Glasgow Benefit Inventory (GBI) and the 
Hearing Handicap Inventory for Adults (HHIA), which were not 
suitable for the purposes of this study. It would thus be reason-
able to take the controls recruited in this study as an accurate 
reference against which the APHAB scores from the irradiated 
patients can be compared. 
  Interestingly, the APHAB scores obtained from the controls 
of this study are similar to the norm values for wide-dynamic 
range compression-capable hearing aids (17). The 50th percen-
tile established from the degree of hearing benefit were EC 
(38%), BN (33%), RV (34%), and AV (-13%). In other words, 
the results obtained in this study fared better on the average 
compared to those with hearing aids (except for AV). 
  SDS improvement levels were also similar, indicating that the 
irradiated group was able to perform to a level comparable to 
and not worse than that of controls. The controls in this study 
also performed to superior levels when compared to another 
study. Orabi et al. (16) reported SDS of 10% at pre-implant lev-
els that improved to 30% nine to twelve months post-implant. 
Norm values for AB words list testing in CI patients has yet to 
be established.
Limitations
A retrospective review of a relatively small sample of patients 
will inherently introduce bias into the study. This is most perti-
nent in the administration of the APHAB in which candidates 
have to score the sub-scales according to their performance from 
memory prior to receiving their CI.
  Another point of contention would also be the use of non-in-
feriority analyses to prove that the irradiated group is not worse 
off when compared to controls. Given that there are no norm 
values established for CI users for the APHAB and SDS, the 
-ΔNI boundary was arbitrarily set as the smallest measurable 
change for the APHAB and was based on clinical judgment for 
what is considered reasonable improvement for the SDS. 
  Due to the constraints of the study, only the objective test of 
AB word list and subjective questionnaire testing of APHAB 
were implemented. Other objective testing such as the Conso-
nant-Nucleus-Consonant words, Central Institute for the Deaf 
sentences, and Hearing in Noise Test sentences were not em-
ployed. Other methods that were not used included subjective 
questionnaires, such as the Glasgow Health Status Inventory 
Questionnaire, which measures the effect of a hearing problem 
on the quality of life (overall life, general, physical health, and 
social support) before and after CI, and the GBI, which assesses 
the benefit to the psychological, social, and emotional aspects of 
quality of life affected by impaired hearing to better measure 
the change in health status brought about by the CI. A wider use 
of clinical tools can further substantiate the trend reflected by 
this study. In addition, there are more studies available that use 
such tools against which a reference can be measured.
  These limitations do not undermine the trend demonstrated 
by this study that CI is clearly able to add to the value of hear-
ing rehabilitation in irradiated patients. In addition, the APHAB 
is a subjective scoring system; the substantial change in degree 
of hearing benefit in the study group itself is indicative of a fa-
vorable outcome for CI in irradiated ears. 
Clinical considerations
In this study group, NPC was the main indication for RT treat-
ment, and the reported 5-year local control rates of NPC in 
modern series ranged from 81 to 85%, with control rates ex-
ceeding 90% for patients with T1 disease (18, 19). Despite the 
effectiveness of RT as a first line treatment, local recurrence still 
represents a major cause of mortality and morbidity in advanced 
stage disease. Magnetic resonance imaging scans are frequently 
employed to rule out tumor recurrence involving the cerebello-
pontine angle as well as for tumor surveillance. Magnets from 
the internal device would need to be removed prior to scanning. 
Surgical considerations would also have to be thought of in cas-
es in which diagnostic biopsies or excision of recurrent tumors 
would be necessary. Bipolar diathermy should thus be used for 
intra-operative coagulation to avoid collateral damage to the CI 
and the delicate surrounding structures.S98    Clinical and Experimental Otorhinolaryngology   Vol. 5, Suppl 1: S93-S98, April 2012
  The effects of RT on temporal bone structures can pose prob-
lems during cochlear implantation. Radiation induced Eusta-
chian tube fibrosis, middle ear effusions, and chronic suppura-
tive otitis media contributing to conductive hearing loss can all 
complicate CI candidacy. Adhesions that form could also prove 
to be a challenge through distortion of the normal ear anatomy, 
especially for the round window niche and the smooth insertion 
of the electrode array. In addition, trismus due to fibrosis of the 
temporomandibular joints and adjacent muscles can pose diffi-
culties during anesthetic intubation for surgery. Osteoradione-
crosis may result and is of concern as a source of infection. RT 
also softens the temporal bone and makes the facial nerve vul-
nerable to iatrogenic damage during temporal bone dissection 
(20).
  Radiation on skin and soft tissues can hamper healing times, 
and utmost care should be exercised in the design of skin inci-
sions, handling of soft tissue, and avoidance of excessive skin 
tension during closure. The wound should also be monitored for 
infections, and preoperative antibiotic coverage should be pro-
vided. 
  In conclusion, this study, performed on a relatively small num-
ber of patients, demonstrated marked improvements in hearing 
measured both objectively and subjectively. The overall hearing 
outcomes after cochlear implantation for post-irradiated pa-
tients were not worse than for patients who have had no prior 
irradiation to ear structures. These findings should be substanti-
ated by further larger scale studies.
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